Molecular Methods Market Size, Share, Trends, Growth Outlook

Molecular Methods Market is estimated to increase at a growth rate of 9.4% CAGR over the forecast period from 2024 to 2030.

The global Molecular Methods Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Reagents & Consumables, Services), By Method (Polymerase Chain Reaction, Immunoassays, Biosensors, Microarrays, Others), By End-user (Pharmaceutical & Biotechnology Industries, Diagnostic Centers, Academic & Research Institutes, Others).

An introduction to Molecular Methods Market in 2024

Facilitating sensitive and specific detection of nucleic acids, proteins, and biomolecules, the Molecular Methods market encompasses a wide array of molecular diagnostic techniques, including PCR, qPCR, DNA sequencing, and hybridization assays, for clinical diagnostics, infectious disease surveillance, and research applications. Molecular methods offer rapid, accurate, and multiplexed detection of pathogens, genetic mutations, and biomarkers, enabling precision medicine approaches and personalized treatment strategies. The market's growth is driven by technological advancements in molecular biology, increasing adoption of molecular diagnostic testing in healthcare settings, and regulatory approvals for novel molecular assays addressing unmet clinical needs.

Molecular Methods Market Trend: Integration of Next-Generation Sequencing (NGS) Technologies

A significant trend in the molecular methods market is the integration of next-generation sequencing (NGS) technologies into molecular diagnostic workflows. NGS technologies have revolutionized molecular analysis by enabling high-throughput sequencing of nucleic acids with unprecedented speed and accuracy. This trend is driven by the increasing demand for comprehensive genetic analysis in various fields, including oncology, infectious diseases, and reproductive health. NGS-based molecular methods offer researchers and clinicians unparalleled insights into the genetic basis of diseases, facilitating personalized treatment approaches and precision medicine initiatives. As NGS technologies continue to evolve and become more accessible, they are expected to play a central role in shaping the future of molecular diagnostics, driving innovation and market growth in the molecular methods sector.

Molecular Methods Market Driver: Growing Need for Accurate and Timely Disease Diagnosis

The primary driver propelling the molecular methods market is the growing need for accurate and timely disease diagnosis. Molecular methods such as polymerase chain reaction (PCR), nucleic acid sequencing, and gene expression analysis are essential tools for detecting and characterizing a wide range of genetic and infectious diseases. With the increasing prevalence of chronic and infectious diseases worldwide, there's a heightened demand for molecular diagnostic tests that offer rapid and reliable results, enabling early detection, treatment optimization, and disease monitoring. This driver is reinforced by healthcare reforms emphasizing preventive care, personalized medicine, and value-based healthcare delivery, driving investments in molecular diagnostic technologies to improve patient outcomes and reduce healthcare costs associated with delayed or inaccurate diagnoses.

Molecular Methods Market Opportunity: Expansion into Point-of-Care Testing (POCT) Solutions

An exciting opportunity in the molecular methods market lies in the expansion into point-of-care testing (POCT) solutions. As the demand for rapid and decentralized diagnostic testing grows, there's potential to develop molecular methods tailored for use at the point of care, such as clinics, pharmacies, and community health centers. POCT molecular assays offer several advantages, including faster turnaround times, reduced reliance on centralized laboratory facilities, and improved patient access to timely diagnosis and treatment. By developing compact, user-friendly molecular testing platforms and assays designed for use in resource-limited settings, manufacturers can tap into new market segments, expand their customer base, and address unmet needs for rapid and accurate molecular diagnostics at the point of care. Additionally, leveraging advances in microfluidics, miniaturization, and automation technologies can further enhance the performance and usability of POCT molecular methods, creating opportunities for innovation and differentiation in the competitive molecular methods market landscape.

Molecular Methods Market Market Segmentation

By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Molecular Methods Market Companies

3M
bioMérieux SA
Bio-Rad Laboratories Inc
Eurofins Scientific
HiMedia Laboratories
NEOGEN Corp
QIAGEN
SGS SA
Thermo Fisher Scientific Inc
Veredus Laboratories

Reasons to Buy the Molecular Methods Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Molecular Methods Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Molecular Methods Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Molecular Methods Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Molecular Methods Market Size Outlook, $ Million, 2021 to 2030
3.2 Molecular Methods Market Outlook by Type, $ Million, 2021 to 2030
3.3 Molecular Methods Market Outlook by Product, $ Million, 2021 to 2030
3.4 Molecular Methods Market Outlook by Application, $ Million, 2021 to 2030
3.5 Molecular Methods Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Molecular Methods Industry
4.2 Key Market Trends in Molecular Methods Industry
4.3 Potential Opportunities in Molecular Methods Industry
4.4 Key Challenges in Molecular Methods Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Molecular Methods Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Molecular Methods Market Outlook by Segments
7.1 Molecular Methods Market Outlook by Segments, $ Million, 2021- 2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

8 North America Molecular Methods Market Analysis and Outlook To 2030
8.1 Introduction to North America Molecular Methods Markets in 2024
8.2 North America Molecular Methods Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Molecular Methods Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

9 Europe Molecular Methods Market Analysis and Outlook To 2030
9.1 Introduction to Europe Molecular Methods Markets in 2024
9.2 Europe Molecular Methods Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Molecular Methods Market Size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

10 Asia Pacific Molecular Methods Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Molecular Methods Markets in 2024
10.2 Asia Pacific Molecular Methods Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Molecular Methods Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

11 South America Molecular Methods Market Analysis and Outlook To 2030
11.1 Introduction to South America Molecular Methods Markets in 2024
11.2 South America Molecular Methods Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Molecular Methods Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

12 Middle East and Africa Molecular Methods Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Molecular Methods Markets in 2024
12.2 Middle East and Africa Molecular Methods Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Molecular Methods Market size Outlook by Segments, 2021-2030
By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
3M
bioMérieux SA
Bio-Rad Laboratories Inc
Eurofins Scientific
HiMedia Laboratories
NEOGEN Corp
QIAGEN
SGS SA
Thermo Fisher Scientific Inc
Veredus Laboratories
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Instruments
Reagents & Consumables
Services
By Method
Polymerase Chain Reaction
Immunoassays
Biosensors
Microarrays
Others
By End-User
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Institutes
Others